ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,437,232 | +645.9% | 212,919 | +757.2% | 0.01% | +500.0% |
| Q2 2023 | $594,894 | +21.6% | 24,839 | -19.1% | 0.00% | -33.3% |
| Q4 2022 | $489,078 | +57.3% | 30,721 | +139.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -87.9% | 12,825 | -73.4% | 0.00% | -91.9% |
| Q4 2020 | $2,578,000 | -67.1% | 48,226 | -70.1% | 0.04% | -67.8% |
| Q2 2020 | $7,825,000 | +2980.7% | 161,431 | +2617.7% | 0.12% | +1337.5% |
| Q4 2019 | $254,000 | – | 5,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |